---
figid: PMC6341905__ol-17-02-2013-g00
figtitle: TGF and RBM5 signaling cascade
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC6341905
filename: ol-17-02-2013-g00.jpg
figlink: /pmc/articles/PMC6341905/figure/f1-ol-0-0-9818/
number: F1
caption: TGF and RBM5 signaling cascade. The left hand side of the image illustrates
  cell growth pathways. Mutations in EGFR, HER2, or KRAS result in enhanced tumor
  cell growth and reduced apoptosis. Mutant RAS (G12V) results in RBM5 expression
  and cell survival. Likewise, increased EGFR and HER2 activation lead to phosphorylation
  and subsequent inhibition of the apoptotic activity of BAD. The right hand side
  of the image illustrates the apoptosis pathway. RBM5 overexpression is associated
  with BCL-XL downregulation and BAX upregulation, which induces cytochrome c release
  from the mitochondria and activates caspase-9 and caspase-3. Antisense RBM5 transfection
  leads to BCL-2 expression. TGF, transforming growth factor; RBM5, RNA-binding protein
  5; EGFR, epidermal growth factor receptor; HER2, human epidermal growth factor receptor
  2; BAD, BCL2 associated agonist of cell death; PI3K, phosphoinositide 3-kinase;
  BCL-2, apoptosis regulator BCL-2; ERK, extracellular signal-regulated kinase; MKP1,
  mitogen activated protein kinase phosphatase 1; SHC, SHC adaptor protein; STAT,
  signal transducer and activator of transcription; KRAS, KRAS proto-oncogene GTPase;
  AP1, activator protein 1; JNK, c-Jun N-terminal kinase; AKT, RAC-α serine/threonine-protein
  kinase; PTEN, phosphatase and tensin homolog; BAX, apoptosis regulator BAX; BCL-XL,
  BCL-2-like 1; Apaf-1, apoptotic protease activating factor-1.
papertitle: Role of RNA-binding protein 5 in the diagnosis and chemotherapeutic response
  of lung cancer.
reftext: Yanling Xu, et al. Oncol Lett. 2019 Feb;17(2):2013-2019.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9543939
figid_alias: PMC6341905__F1
figtype: Figure
redirect_from: /figures/PMC6341905__F1
ndex: 36ba3e1f-deea-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6341905__ol-17-02-2013-g00.html
  '@type': Dataset
  description: TGF and RBM5 signaling cascade. The left hand side of the image illustrates
    cell growth pathways. Mutations in EGFR, HER2, or KRAS result in enhanced tumor
    cell growth and reduced apoptosis. Mutant RAS (G12V) results in RBM5 expression
    and cell survival. Likewise, increased EGFR and HER2 activation lead to phosphorylation
    and subsequent inhibition of the apoptotic activity of BAD. The right hand side
    of the image illustrates the apoptosis pathway. RBM5 overexpression is associated
    with BCL-XL downregulation and BAX upregulation, which induces cytochrome c release
    from the mitochondria and activates caspase-9 and caspase-3. Antisense RBM5 transfection
    leads to BCL-2 expression. TGF, transforming growth factor; RBM5, RNA-binding
    protein 5; EGFR, epidermal growth factor receptor; HER2, human epidermal growth
    factor receptor 2; BAD, BCL2 associated agonist of cell death; PI3K, phosphoinositide
    3-kinase; BCL-2, apoptosis regulator BCL-2; ERK, extracellular signal-regulated
    kinase; MKP1, mitogen activated protein kinase phosphatase 1; SHC, SHC adaptor
    protein; STAT, signal transducer and activator of transcription; KRAS, KRAS proto-oncogene
    GTPase; AP1, activator protein 1; JNK, c-Jun N-terminal kinase; AKT, RAC-α serine/threonine-protein
    kinase; PTEN, phosphatase and tensin homolog; BAX, apoptosis regulator BAX; BCL-XL,
    BCL-2-like 1; Apaf-1, apoptotic protease activating factor-1.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Egfr
  - Shc
  - ras
  - Ras64B
  - Ras85D
  - Raf
  - bsk
  - cass
  - Debcl
  - AP-1gamma
  - Jra
  - kay
  - Akt
  - Erk7
  - rl
  - Stat92E
  - en
  - Pen
  - peng
  - peo
  - ten
  - Dronc
  - Dark
  - Decay
  - Dsor1
  - Mtk
  - Pten
  - C15
  - Cli
  - eya
  - TGFA
  - EGF
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - RBM5
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAPK8
  - MAPK9
  - MAPK10
  - BAD
  - BAX
  - BCL2
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - FOSL1
  - FOSL2
  - AKT1
  - AKT2
  - AKT3
  - EPHB2
  - MAPK1
  - MAPK3
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - PUM3
  - PCSK1N
  - TSPAN33
  - APAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - PTEN
  - DCLK1
  - ADGRL1
  - CLU
  - AKR1C4
  - GZMB
  - POLR3K
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
